3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
2
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Melanoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioblastoma
1
Esophageal Neoplasms
1
Disease
1
Colorectal Neoplasms
1
Carcinoma, Bronchogenic
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
ruxolitinib
3
venetoclax
2
fludarabine phosphate
2
duvelisib
2
thymoglobulin
1
romidepsin
1
itacitinib
1
fludarabine
1
Whole-Body Irradiation
1
Stem Cell Transplantation
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Lisaftoclax
1
Depsipeptides
1
Cyclosporins
1
Cyclosporine
1
Cladribine
1
Busulfan
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Prolymphocytic, T-Cell
×
Interleukin-15
×
1 year
×
Clear all
No trials found.